Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 15 open reading frame 39 is a cytosolic protein encoded by the C15orf39 gene, located on chromosome 15q24.2 with at least seven transcript isoforms, the longest encoding a 1047 amino acid protein[2]. The protein features a high proline content, four predicted domains—including a proline-rich domain, alanine-rich domain, viral tegument-like UL36 domain, and WASP-homology 2 (WH2) actin-binding domain—and undergoes post-translational modifications such as phosphorylation, acetylation, sumoylation, and O-glycosylation at conserved sites[2]. C15orf39 has demonstrated interactions with proteins involved in ribosomal translation and cytoplasmic transport (e.g., RPLP1, EIF4ENIF1), suggesting a possible structural or regulatory role, but its exact biological function remains uncharacterized. Expression is highest in neuronal ganglia, blood, and heart, and a possible altered role has been noted in Hepatoerythropoietic Porphyria, but direct involvement in disease or therapeutic targeting is unconfirmed[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 15 open reading frame 39 (C15orf39).